Concerns rise over waived-consents

Jun 14, 2006

Concern is growing in the Untied States over waived consents that could lead a person to unknowingly become a test subject in a medical trial.

Critics want to know whether people understand how consents work and whether they are given adequate protection when they become test subjects, reports USA Today.

The report said Wednesday's edition of the Journal of American Medical Association talks of a trial that was halted because a device used to revive cardiac-arrest victims failed to save more lives than when rescuers performed cardio-pulmonary resuscitation.

The JAMA study says as many as 10 people in one city may not have been revived because of their participation.

The newspaper said patients in such studies, which are often financed by manufacturers of the tested product, are treated under a broad federal rule. That rule allows researchers to test emergency treatments on patients with specific, life-threatening medical conditions without their explicit consent as long as they remain under close watch of independent reviewers.

Supporters say there is no substitute for such testing in emergency cases of life-and-death situations.

Copyright 2006 by United Press International

Explore further: Both weight loss and weight gain linked with increased fracture risk

add to favorites email to friend print save as pdf

Related Stories

Bring on driverless cars

Jan 21, 2015

Imagine no more gridlock, road rage and drunk driving—and 90 percent fewer car accidents. You could well be able to sit back and enjoy the ride sooner than you think, according to the engineers who are ...

Fiery risk? Air shipments of batteries questioned

Dec 02, 2014

Dramatic U.S. government test results raise new concern that bulk shipments of rechargeable lithium batteries carried as cargo on passenger planes are susceptible to fires or explosions that could destroy ...

Recommended for you

How does DPP-4 inhibition affect liver function?

52 minutes ago

(HealthDay)—Dipeptidyl peptidase-4 (DPP-4) inhibition may attenuate hepatic steatosis and insulin resistance induced by the Western diet (WD) through hepatic lipid remodeling and modulation of hepatic mitochondrial ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.